This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Baylor College of Medicine, Beijing University of Technology, Peptides International, Inc.. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Victoria, AU (2017)
- Rosanna, AU (2019)
Company Filing History:
2 out of 617 
2 out of 389 
2 out of 2 
Years Active: 2017-2019
Title: Innovations of Raymond S. Norton in Autoimmune Disease Treatment
Introduction
Raymond S. Norton is a notable inventor based in Rosanna, Australia. He has made significant contributions to the field of medical science, particularly in the development of therapeutic agents for autoimmune diseases. With a total of 2 patents, his work focuses on potassium channel blockers and their applications in treating various autoimmune conditions.
Latest Patents
Norton’s latest patents include innovative approaches to treating autoimmune diseases. One patent details the use of novel analogues of the sea anemone toxin ShK. These analogues are designed to act as therapeutic agents for conditions such as multiple sclerosis and rheumatoid arthritis. The analogues consist of a ShK toxin polypeptide with an N-terminal extension that includes a specific amino acid sequence. This design aims to enhance the efficacy of the treatment by targeting potassium channels selectively.
Another patent involves a scorpion toxin analogue, which also serves as a therapeutic agent for autoimmune diseases. This peptide analogue features an amino acid substitution at a critical position in the wild-type peptide sequence. It exhibits selectivity for Kv1.3 over Kv1.1 and other potassium channels, making it a promising candidate for further research and development.
Career Highlights
Throughout his career, Raymond S. Norton has worked with prestigious institutions, including Beijing University of Technology and Baylor College of Medicine. His research has significantly advanced the understanding of potassium channels and their role in autoimmune diseases.
Collaborations
Norton has collaborated with esteemed colleagues such as Michael W. Pennington and Christine Beeton. These partnerships have contributed to the successful development of his innovative therapeutic agents.
Conclusion
Raymond S. Norton’s contributions to the field of autoimmune disease treatment through his patents and collaborations highlight his role as a leading inventor in medical science. His innovative approaches continue to pave the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile